Comparing the effects of botulinum Toxin-A and cetirizine on the treatment of allergic rhinitis

Allergology International

Volumn 62, Issue 2, 2013, Pages 245-249

  Hashemi, Sayyed Mostafa ^a   Okhovat, Ahmadreza ^a   Amini, Saghi ^a   Pourghasemian, Mahdi ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Allergic rhinitis; Botulinum toxin type a; Histamine h1 antagonist

Indexed keywords

BOTULINUM TOXIN A; CETIRIZINE;

ADULT; ALLERGIC RHINITIS; ARTICLE; BLURRED VISION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRY NOSE; EPISTAXIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHINASTHMA QUESTIONNAIRE; SINGLE DRUG DOSE; TREATMENT OUTCOME;

EID: 84878969442     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.12-OA-0510     Document Type: Article

References (21)

1. Mirsaid Ghazi B, Imamzadehgan R, Aghamohammadi A, Darakhshan Davari R, Rezaei N. Frequency of allergic rhinitis in school-age children (7-18 Years) in Tehran. Iran J Allergy Asthma Immunol 2003;2:181-4.
2. Katelaris CH, Lee BW, Potter PC et al. Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America. Clin Exp Allergy 2012;42:186-207.
3. Sin B, Togias A. Pathophysiology of allergic and nonallergic rhinitis. Proc Am Thorac Soc 2011;8:106-14.
4. Jones AS. Autonomic reflexes and non-allergic rhinitis. Al-lergy 1997;52:14-9.
5. Bousquet J, Khaltaev N, Cruz AA et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collabo-ration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160.
6. Greiner AN, Meltzer EO. Overview of the treatment of al-lergic rhinitis and nonallergic rhinopathy. Proc Am Thorac Soc 2011;8:121-31.
7. Schantz EJ, Johnson EA. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Micro-biol Rev 1992;56:80-99.
8. Simpson LL. Identification of the major steps in botulinum toxin action. Annu Rev Pharmacol Toxicol 2004;44:167-93.
9. Thant ZS, Tan EK. Emerging therapeutic applications of botulinum toxin. Med Sci Monit 2003;9:RA40-8.
10. Rohrbach S, Junghans K, Kohler S, Laskawi R. Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis. Head Face Med 2009;5:18.
11. Yang TY, Jung YG, Kim YH, Jang TY. A comparison of the effects of botulinum toxin A and steroid injection on nasal allergy. Otolaryngol Head Neck Surg 2008;139:367-71.
12. Unal M, Sevim S, Dogu O, Vayisoglu Y, Kanik A. Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial. Acta Otolaryngol 2003;123:1060-3.
13. Baiardini I, Pasquali M, Giardini A et al. Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 2003;58:289-94.
14. Meltzer EO, Bukstein DA. The economic impact of allergic rhinitis and current guidelines for treatment. Ann Allergy Asthma Immunol 2011;106:S12-6.
15. Thorn F, Celius H, Odegard T, Mandla R, Hexeberg E. Assessment of efficacy and impact on work productivity and attendance after a mandatory switch to generic second-generation antihistamines: results of a patient survey in Norway. Clin Mol Allergy 2011;9:5.
16. Kim KS, Kim SS, Yoon JH, Han JW. The effect of botulinum toxin type A injection for intrinsic rhinitis. J Laryngol Otol 1998;112:248-51.
17. Rohrbach S, Olthoff A, Laskawi R, Giefer B, Gotz W. Botulinum toxin type A induces apoptosis in nasal glands of guinea pigs. Ann Otol Rhinol Laryngol 2001;110:1045-50.
18. Özcan C, Vayisoglu Y, Do u O, Görür K. The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis. Am J Otolaryngol 2006;27:314-8.
19. Braun T, Gürkov R, Kramer MF, Krause E. Septal injection of botulinum neurotoxin A for idiopathic rhinitis: a pilot study. Am J Otolaryngol 2012;33:64-7.
20. Sapci T, Yazici S, Evcimik MF et al. Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia. Rhinology 2008;46:45-51.
21. Unal M. Investigate the effect of botulinum toxin type A (BTX-A) on nasal symptoms inpatients with allergic rhinitis. Acta Otolaryngol 2005;125:223.